Is Blood Eosinophil Count a Biomarker for Chronic Obstructive Pulmonary Disease in a Real-World Clinical Setting? Predictive Property and Longitudinal Stability in Japanese Patients

Is Blood Eosinophil Count a Biomarker for Chronic Obstructive Pulmonary Disease in a Real-World Clinical Setting? Predictive Property and Longitudinal Stability in Japanese Patients

The authors examined predictive properties and the longitudinal stability of blood eosinophil count (BEC) or three strata (<100 cells/mm<sup>3</sup>, 100–299 cells/mm<sup>3</sup> and ≥300 cells/mm<sup>3</sup>) in patients with chronic obstructive pulmonary dise...

Full description

Bibliographic Details
Main Authors:	Koichi Nishimura, Masaaki Kusunose, Ryo Sanda, Mio Mori, Ayumi Shibayama, Kazuhito Nakayasu
Format:	Article
Language:	English
Published:	MDPI AG 2021-02-01
Series:	Diagnostics
Subjects:	inhaled corticosteroids (ICS) chronic obstructive pulmonary disease (COPD) blood eosinophil count (BEC) eosinophil the Global Initiative for Chronic Obstructive Lung Disease (GOLD) acute exacerbation of COPD (AECOPD)
Online Access:	https://www.mdpi.com/2075-4418/11/3/404

Similar Items

Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population
by: Vestbo J, et al.
Published: (2019-04-01)

Blood eosinophils and inhaled corticosteroids in patients with COPD: systematic review and meta-analysis
by: Cheng SL
Published: (2018-09-01)

Relationship Between Blood Eosinophils and Systemic Corticosteroid Therapy in COPD Exacerbation
by: Gong Y, et al.
Published: (2022-09-01)

Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts
by: Cheng SL, et al.
Published: (2016-09-01)

Clinical implications of blood eosinophil count in patients with non-asthma–COPD overlap syndrome COPD
by: Song JH, et al.
Published: (2017-08-01)

Blood eosinophil count in patients with COPD on inhaled corticosteroids in comparison with healthy smoker and nonsmoker controls
by: Noha Othman Ahmed, et al.
Published: (2021-01-01)

Exacerbation and Cardiovascular Events in Eosinophilic Chronic Obstructive Pulmonary Disease
by: Mami Orimo, et al.
Published: (2023-04-01)

Pulmonologists’ Opinion on the Use of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease Patients in Spain: A Cross-Sectional Survey
by: Miravitlles M, et al.
Published: (2022-07-01)

Comparison of Disease Severity Classifications of Chronic Obstructive Pulmonary Disease: GOLD vs. STAR in Clinical Practice
by: Koichi Nishimura, et al.
Published: (2024-03-01)

COPD patients prescribed inhaled corticosteroid in primary care: time for re-assessment based on exacerbation rate and blood eosinophils?
by: Osman Savran, et al.
Published: (2021-02-01)

Inhaled corticosteroids, blood eosinophils, and FEV1 decline in patients with COPD in a large UK primary health care setting
by: Whittaker HR, et al.
Published: (2019-05-01)

Variability of Blood Eosinophil Count at Stable-State in Predicting Exacerbation Risk of Chronic Obstructive Pulmonary Disease
by: Kwok WC, et al.
Published: (2023-06-01)

Mepolizumab in the treatment of eosinophilic chronic obstructive pulmonary disease
by: Mkorombindo T, et al.
Published: (2019-08-01)

Risk of Malignancy in Patients with Asthma-COPD Overlap Compared to Patients with COPD without Asthma
by: Barbara Bonnesen, et al.
Published: (2022-06-01)

Neutrophil to lymphocyte ratio is a better indicator of COPD exacerbation severity in neutrophilic endotypes than eosinophilic endotypes
by: Aksoy E, et al.
Published: (2018-09-01)

High versus Medium Dose of Inhaled Corticosteroid in Chronic Obstructive Lung Disease: A Systematic Review and Meta-Analysis
by: Archontakis Barakakis P, et al.
Published: (2023-04-01)

Using Blood Eosinophil Count as a Biomarker to Guide Corticosteroid Treatment for Chronic Obstructive Pulmonary Disease
by: Pradeesh Sivapalan, et al.
Published: (2021-02-01)

Relationship between Peripheral Blood Eosinophil Count and Neutrophil/Lymphocyte Ratio with Number of Attacks Leading to Hospital Admission in Chronic Obstructive Pulmonary Disease
by: Maryam Mirzaee, et al.
Published: (2020-12-01)

Is Frailty a Mortality Predictor in Subjects with Chronic Obstructive Pulmonary Disease?
by: Nishimura K, et al.
Published: (2023-12-01)

Bronchiectasis-COPD Overlap Syndrome: Role of Peripheral Eosinophil Count and Inhaled Corticosteroid Treatment
by: Grace Oscullo, et al.
Published: (2023-10-01)

Reduction of corticosteroid use in outpatient treatment of exacerbated COPD - Study protocol for a randomized, double-blind, non-inferiority study, (The RECUT-trial)
by: Pascal Urwyler, et al.
Published: (2019-12-01)

Evaluation of exacerbations and blood eosinophils in UK and US COPD populations
by: Claus F. Vogelmeier, et al.
Published: (2019-08-01)

Eosinophils and Chronic Respiratory Diseases in Hospitalized COVID-19 Patients
by: Marcela Valverde-Monge, et al.
Published: (2021-06-01)

Stability of Blood Eosinophils in COPD with Multiple Acute Exacerbations Within 1 Year and Its Relationship with Prognosis
by: Gong Y, et al.
Published: (2022-12-01)

A systematic review and integrated analysis of biologics that target Type 2 inflammation to treat COPD with increased peripheral blood eosinophils
by: Hiroshi Ohnishi, et al.
Published: (2022-06-01)

Are Fatigue and Pain Overlooked in Subjects with Stable Chronic Obstructive Pulmonary Disease?
by: Koichi Nishimura, et al.
Published: (2021-11-01)

Blood eosinophil variability in patients presenting with acute exacerbations of COPD within the past year and its correlation with treatment plan
by: Samir Mohamed Mahmoud Fahyim, et al.
Published: (2024-03-01)

The Role of the Cumulative Illness Rating Scale (CIRS) in Estimating the Impact of Comorbidities on Chronic Obstructive Pulmonary Disease (COPD) Outcomes: A Pilot Study of the MACH (Multidimensional Approach for COPD and High Complexity) Study
by: Domenico Di Raimondo, et al.
Published: (2023-11-01)

Meta-analysis of the impact of eosinophilia and its baseline characteristics on the exacerbation of chronic obstructive pulmonary disease
by: Lan-miao Li, et al.
Published: (2023-05-01)

The association between blood eosinophil percent and bacterial infection in acute exacerbation of chronic obstructive pulmonary disease
by: Choi J, et al.
Published: (2019-05-01)

Blood eosinophil count, a marker of inhaled corticosteroid effectiveness in preventing COPD exacerbations in post-hoc RCT and observational studies: systematic review and meta-analysis
by: Timothy H. Harries, et al.
Published: (2020-01-01)

Blood and sputum eosinophilia in COPD exacerbation
by: Laila Ashour Helala, et al.
Published: (2022-09-01)

Predictors of Influenza PCR Positivity in Acute Exacerbations of Chronic Obstructive Pulmonary Disease
by: Chen CYJ, et al.
Published: (2022-01-01)

Prediction value of neutrophil and eosinophil count at risk of COPD exacerbation
by: Tzu-Tao Chen, et al.
Published: (2023-12-01)

Clinical experience of using formoterol/budesonide in patients with chronic obstructive pulmonary disease
by: I. V. Demko, et al.
Published: (2021-10-01)

Relationship between blood eosinophils, clinical characteristics, and mortality in patients with COPD
by: Zysman M, et al.
Published: (2017-06-01)

Blood eosinophil percentage as a predictor of response to inhaled corticosteroid in bronchiectasis
by: Wang Chun Kwok, et al.
Published: (2023-06-01)

Association Between Blood Eosinophils and Mortality in Critically Ill Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Retrospective Cohort Study
by: Yang J, et al.
Published: (2021-02-01)

Burden of disease associated with a COPD eosinophilic phenotype
by: Ortega H, et al.
Published: (2018-08-01)

Lack of Association between Inhaled Corticosteroid Use and the Risk of Future Exacerbation in Patients with GOLD Group A Chronic Obstructive Pulmonary Disease
by: Sun Hye Shin, et al.
Published: (2022-05-01)